Patents Examined by E. White
  • Patent number: 7622575
    Abstract: The present invention is directed to methods of using glucan compositions, comprising water insoluble microparticulate glucans, in the treatment of connective tissue injuries. The water insoluble microparticulate glucans used in the compositions comprise branched ?-(1,3)(1,6) glucan. The glucan compositions used in the present invention are essentially free of unbranched ?-(1,3)(1,6) glucan and non-glucan components.
    Type: Grant
    Filed: August 4, 2006
    Date of Patent: November 24, 2009
    Assignee: Novogen Research Pty. Ltd.
    Inventor: Graham Edmund Kelly
  • Patent number: 7375214
    Abstract: A free-flowing, hydrophobic starch composition has a near-neutral dry product pH. Methods for making the hydrophobic starch composition by preparing an aqueous mixture comprising a starch, a siliconate, and an acid, where the aqueous mixture has a near-neutral pH, and drying the starch solids to obtain a hydrophobic starch. Novel fuel compositions comprise hydrophobic starch which can be used in internal combustion engines, such as diesel engines. Hydrophobic starch compositions may be used as fuels or fuel components. Novel methods of fueling and operating internal combustion engines use hydrophobic starch as fuel or fuel components.
    Type: Grant
    Filed: February 22, 2005
    Date of Patent: May 20, 2008
    Assignee: LenLo Chem, Inc.
    Inventor: Leonard T. Lewis
  • Patent number: 5401777
    Abstract: The invention relates to the use of preparations of the plant Curcuma longa or other curcumin-containing plants, curcumin or curcumin derivatives for the prophylaxis and/or treatment of conditions associated with excessive formation of leucotrienes and/or prostaglandins and to the use of preparations of the plant Curcuma longa or other curcumin-containing plants, curcumin or curcumin derivatives for the production of medicaments for the prophylaxis and/or treatment of conditions associated with excessive formation of leucotrienes and/or prostaglandins.
    Type: Grant
    Filed: November 10, 1992
    Date of Patent: March 28, 1995
    Assignee: Steigerwald Arzneimittelwerk GmbH
    Inventors: H. P. T. Ammon, Hasan Safayhi, Samuel N. Okpanyi
  • Patent number: 4874852
    Abstract: Disclosed are a glycosidation catalyst comprising at least one of heteropoly acids represented by the formulaH.sub.a X.sub.p M.sub.q O.sub.r .multidot.bH.sub.2 Owherein X is P, As, Si or Ge, M is at least one species selected from the group consisting of Mo, W and V, a is 3 4 or 6, b is an integer of 0 to 30, p is 1 or 2, q is 12 or 18, and r is 40 or 62, with the proviso that when X is P or As, a is 3 or 6; when X is Si or Ge, a is 4; and further (1) when X is P or As and a is 3, or when X is Si or Ge and a is 4, M is at least one species selected from the group consisting of Mo, W and V, p is 1, q is 12 and r is 40; and (2) when X is P or As and a is 6, M is Mo or W, p is 2, q is 18 and r is 62, and a process for preparing a glycoside derivative by using said catalyst.
    Type: Grant
    Filed: March 10, 1989
    Date of Patent: October 17, 1989
    Assignee: Nippon Fine Chemical Co., Ltd.
    Inventors: Keisuke Kinomura, Sadaya Kitazawa, Yasushi Takata, Toshiyuki Sakakibara